SCHEMBL1220165

SCHEMBL1220165

CCCCCCCCCCCCOC(=O)CC[C@H](N)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 4/20 0.64
P2RY10 O00398 8/20 0.56
GPR34 Q9UPC5 3/20 0.56
HTR2C P28335 1/20 0.55
NAAA Q02083 1/20 0.53
DGKA P23743 1/20 0.53
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17537070 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL17537075 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL17537068 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL1697599 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL7351258 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL9005485 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL17010720 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL17537066 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL15260354 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA
SCHEMBL3488210 1.00 NOD1 (0.64) NOD1P2RY10GPR34HTR2CNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850110-B Synthesis method of ceramide-like compound containing glyceride structure 苏州元素集化学工业有限公司 2024-02-20 CN claimed
WO-2023202443-A1 FINISHING LIQUID COMPOSITION AND USE THEREOF 华熙生物科技股份有限公司 2023-10-26 WO claimed
CN-116679536-A Bubble-free cleaning-free tank developing solution and configuration method thereof 深圳市虹喜科技发展有限公司 2023-09-01 CN claimed
CN-115887290-A Mild and transparent amino acid shampoo and preparation method thereof 天津郁美净集团有限公司 2023-04-04 CN claimed
CN-112076111-B Dandruff-removing shampoo composition 广州市科能化妆品科研有限公司 2022-11-08 CN claimed
EP-2501777-B1 BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX GRUNE GUERRY L (US) 2022-10-26 EP claimed
CN-114426810-A Heat transfer fluid and preparation method and application thereof 中国石油化工股份有限公司 2022-05-03 CN claimed
CN-114224765-A Amino acid shampoo and preparation method thereof 上海佰太生物科技有限公司 2022-03-25 CN claimed
CN-113632803-A Quaternary ammonium salt complex iodine disinfectant and preparation method thereof 瑞普(天津)生物药业有限公司 2021-11-12 CN claimed
CN-111329824-A Hand sanitizer with strong sterilization capability 东元科技有限公司 2020-06-26 CN claimed
CN-106467725-B A kind of biomass drilling base liquid, preparation method and its application 中石化石油工程技术服务有限公司 2019-04-12 CN claimed
EP-2934506-B1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT Pierre Fabre Dermo-Cosmétique (FR) 2018-01-17 EP claimed
CN-106351006-A Fiber cloth with color protection and adsorption functions as well as preparation method and application thereof 广州都赢电子商务有限公司 2017-01-25 CN claimed
US-9493401-B2 Glutamate derivatives for topical use as immunomodulatory active ingredient PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-11-15 US claimed
US-20160060208-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-03-03 US claimed
CN-103451037-B Sterilization laundry detergent containing polylysine TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-12-23 CN claimed
EP-2934506-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT Pierre Fabre Dermo-Cosmétique (FR) 2015-10-28 EP claimed
WO-2014096155-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2014-06-26 WO claimed
CN-103451037-A Sterilization laundry detergent containing epsilon-polylysine UNIV TIANJIN SCIENCE & TECH 2013-12-18 CN claimed
CN-119924310-A Compositions containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and methods of treating keratin materials using such compositions 莱雅公司 2025-05-06 CN disclosed
CN-115843810-B Sterilization preparation and application thereof 沈阳中化农药化工研发有限公司 2025-04-18 CN disclosed
CN-119709458-A Bacillus amyloliquefaciens and application thereof in improving lipase activity 安徽农业大学 2025-03-28 CN disclosed
CN-118813325-A Semisynthetic cutting fluid and preparation method thereof 中国石油化工股份有限公司 2024-10-22 CN disclosed
US-20240254096-A1 ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS ELKIMIA INC (CA) 2024-08-01 US disclosed
EP-4367094-A1 ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS Elkimia Inc. (CA) 2024-05-15 EP disclosed
CN-114129721-B Amphiphilic imiquimod grafted gamma-polyglutamic acid lauryl ester and application thereof 江苏省农业科学院 2024-05-07 CN disclosed
CN-117881655-A Ultraviolet radiation and visible radiation absorbing compounds 爱尔克米亚公司 2024-04-12 CN disclosed
CN-115040495-B Oral nanometer drug delivery system mediated by small molecule nutrient substances 四川大学 2024-03-15 CN disclosed
CN-115850110-B Synthesis method of ceramide-like compound containing glyceride structure 苏州元素集化学工业有限公司 2024-02-20 CN disclosed
CN-113194913-B Fragrance gel 莱雅公司 2024-01-02 CN disclosed
CN-116003281-B Method for synthesizing ceramide-like compound by using dicarboxylic acid structure 苏州元素集化学工业有限公司 2023-10-03 CN disclosed
CN-115192542-B Oral nanometer drug delivery system mediated by small molecule nutrient substances 四川大学 2023-09-08 CN disclosed
CN-116679536-A Bubble-free cleaning-free tank developing solution and configuration method thereof 深圳市虹喜科技发展有限公司 2023-09-01 CN disclosed
WO-2023145469-A1 COSMETIC 株式会社 資生堂 2023-08-03 WO disclosed
EP-4208195-A1 LIVE-ATTENUATED RNA HYBRID VACCINE TECHNOLOGY Access to Advanced Health Institute (US) 2023-07-12 EP disclosed
CN-113632803-B Quaternary ammonium salt complex iodine disinfectant and preparation method thereof 瑞普(天津)生物药业有限公司 2023-06-20 CN disclosed
CN-113194722-B Antimicrobial mixtures containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and 4-hydroxyacetophenone, and compositions containing the same 莱雅公司 2023-05-05 CN disclosed
CN-116003281-A Method for synthesizing ceramide-like compound by using dicarboxylic acid structure 苏州元素集化学工业有限公司 2023-04-25 CN disclosed
CN-115887290-A Mild and transparent amino acid shampoo and preparation method thereof 天津郁美净集团有限公司 2023-04-04 CN disclosed
CN-115850110-A Synthesis method of ceramide compound containing glyceride structure 苏州元素集化学工业有限公司 2023-03-28 CN disclosed
CN-115843810-A Bactericidal preparation and application thereof 沈阳中化农药化工研发有限公司 2023-03-28 CN disclosed
EP-4129290-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING EPIDEMIC RNA VIRAL INFECTIOUS DISEASE Shin Poong Pharmaceutical Co., Ltd. (KR) 2023-02-08 EP disclosed
WO-2023279205-A1 ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS elkimia inc. (CA) 2023-01-12 WO disclosed
CN-114304164-B Bactericidal preparation and application thereof 沈阳中化农药化工研发有限公司 2022-12-13 CN disclosed
EP-2501777-B1 BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX GRUNE GUERRY L (US) 2022-10-26 EP disclosed
CN-115192542-A Oral nano drug delivery system mediated by small molecular nutrient substances 四川大学 2022-10-18 CN disclosed
CN-115040495-A Oral nano drug delivery system mediated by small molecular nutrient substances 四川大学 2022-09-13 CN disclosed
CN-112755005-B Oral nano drug delivery system mediated by small molecular nutrient substances 四川大学 2022-05-13 CN disclosed
CN-114426810-A Heat transfer fluid and preparation method and application thereof 中国石油化工股份有限公司 2022-05-03 CN disclosed
CN-114304164-A Bactericidal preparation and application thereof 沈阳中化农药化工研发有限公司 2022-04-12 CN disclosed
CN-113632803-A Quaternary ammonium salt complex iodine disinfectant and preparation method thereof 瑞普(天津)生物药业有限公司 2021-11-12 CN disclosed
CN-112755005-A Oral nano drug delivery system mediated by small molecular nutrient substances 四川大学 2021-05-07 CN disclosed
US-10905744-B2 Pharmaceutical formulations for the oral delivery of peptide drugs CYPRUMED GMBH (AT) 2021-02-02 US disclosed
CN-111329824-A Hand sanitizer with strong sterilization capability 东元科技有限公司 2020-06-26 CN disclosed
CN-111329824-A Hand sanitizer with strong sterilization capability 东元科技有限公司 2020-06-26 CN disclosed
CN-106467725-B A kind of biomass drilling base liquid, preparation method and its application 中石化石油工程技术服务有限公司 2019-04-12 CN disclosed
US-20180280481-A1 PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS CYPRUMED GMBH (AT) 2018-10-04 US disclosed
CN-106632395-B A kind of loop coil amino acid esters compound and its preparation method and application 辽宁大学 2018-09-21 CN disclosed
EP-2934506-B1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT Pierre Fabre Dermo-Cosmétique (FR) 2018-01-17 EP disclosed
CN-106632395-A Spiro-amino acid ester compound, and preparation method and application thereof 辽宁大学 2017-05-10 CN disclosed
WO-2017060500-A1 PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS CYPRUMED GMBH (AT) 2017-04-13 WO disclosed
CN-106467725-A A kind of biomass drilling base liquid, its preparation method and its application 中石化石油工程技术服务有限公司 2017-03-01 CN disclosed
CN-106351006-A Fiber cloth with color protection and adsorption functions as well as preparation method and application thereof 广州都赢电子商务有限公司 2017-01-25 CN disclosed
US-9493401-B2 Glutamate derivatives for topical use as immunomodulatory active ingredient PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-11-15 US disclosed
US-9493401-B2 Glutamate derivatives for topical use as immunomodulatory active ingredient PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-11-15 US disclosed
US-9493401-B2 Glutamate derivatives for topical use as immunomodulatory active ingredient PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-11-15 US disclosed
US-20160060208-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-03-03 US disclosed
US-20160060208-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-03-03 US disclosed
US-20160060208-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-03-03 US disclosed
CN-103269713-B Antigen delivery platform NOVARTIS AG (CH) 2016-01-20 CN disclosed
CN-103451037-B Sterilization laundry detergent containing polylysine TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-12-23 CN disclosed
EP-2934506-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT Pierre Fabre Dermo-Cosmétique (FR) 2015-10-28 EP disclosed
CN-104853770-A Immunogenic compositions and uses thereof NOVARTIS AG 2015-08-19 CN disclosed
CN-104814881-A Moisturizing and repairing composition and epidermis biomimetic membrane liquid crystal complex constructed therefrom GUANGZHOU HUAANTANG BIOTECHNOLOGY CO LTD 2015-08-05 CN disclosed
CN-102812969-B Botanical antiviral agent, and preparation method and application thereof SHAANXI SUNGER ROAD BIO SCI CO 2014-07-09 CN disclosed
WO-2014096155-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2014-06-26 WO disclosed
WO-2014096155-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2014-06-26 WO disclosed
CN-103781470-A Oil-in-water emulsions that contain nucleic acids NOVARTIS AG 2014-05-07 CN disclosed
CN-103451037-A Sterilization laundry detergent containing epsilon-polylysine UNIV TIANJIN SCIENCE & TECH 2013-12-18 CN disclosed
CN-101300267-B Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof FLAMEL TECH SA 2013-10-16 CN disclosed
CN-103269713-A Antigen delivery platforms NOVARTIS AG 2013-08-28 CN disclosed
US-8293255-B2 Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes FLAMEL TECHNOLOGIES (FR) 2012-10-23 US disclosed
US-8206744-B2 Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications FLAMEL TECHNOLOGIES (FR) 2012-06-26 US disclosed
CN-101505715-B Solid cosmetic composition containing polyester OREAL 2012-03-21 CN disclosed
US-7919572-B2 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications FLAMEL TECHNOLOGIES (FR) 2011-04-05 US disclosed
US-20110044930-A1 COPOLYHYDROXYALKYLGLUTAMINES FUNCTIONALISED WITH HYDROPHOBIC GROUPS, AND USES THEREOF, ESPECIALLY IN THERAPEUTICS DEERFIELD PRIVATE DESIGN FUND II, L.P. 2011-02-24 US disclosed
US-20100098656-A1 Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications FLAMEL TECHNOLOGIES (FR) 2010-04-22 US disclosed
US-7683024-B2 Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications FLAMEL TECHNOLOGIES (FR) 2010-03-23 US disclosed
US-20100048735-A1 POLYAMINOACIDS FUNCTIONALIZED WTIH ALPHA-TOCOPHEROL, AND USES THEREOF, ESPECIALLY THERAPEUTIC USES FLAMEL TECHNOLOGIES, S.A. (FR) 2010-02-25 US disclosed
US-20100034886-A1 Polyglutamic Acids Functionalised by Histidine Derivatives and Hydrophobic Groups and the Uses Thereof, in Particular for Therapeutic Purposes FLAMEL TECHNOLOGIES, S.A. (FR) 2010-02-11 US disclosed
US-7659365-B2 Telechelic homopolyamino acids functionalized with hydrophobic groups, and their applications, especially therapeutic applications FLAMEL TECHNOLOGIES (FR) 2010-02-09 US disclosed
US-20090305948-A1 Branched Polyamino Acids Functionalized with Hydrophobic Groups, and Applications Thereof Particularly Therapeutic Applications DEERFIELD PRIVATE DESIGN FUND II, L.P. 2009-12-10 US disclosed
CN-101505715-A Solid cosmetic composition containing polyester OREAL (FR) 2009-08-12 CN disclosed
CN-101300267-A Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof in particular for therapeutic purposes FLAMEL TECH SA (FR) 2008-11-05 CN disclosed
CN-101151023-A Copolyhydroxyalkylglutamines which are functionalised with hydrophobic groups and applications thereof, such as in therapeutics FLAMEL TECH SA (FR) 2008-03-26 CN disclosed
EP-1857095-A1 Fine emulsion of oil in water L'OREAL (FR) 2007-11-21 EP disclosed
US-20070265192-A1 Telechelic Homopolyamino Acids Functionalized with Hydrophobic Groups, and Their Applications, Especially Therapeutic Applications FLAMEL IRELAND LIMITED (IE) 2007-11-15 US disclosed
US-20070178126-A1 Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses FLAMEL TECHNOLOGIES (FR) 2007-08-02 US disclosed
EP-1576081-B1 USE OF MULTIFUNCTIONAL SURFACE ACTIVE AGENTS TO CLEAN CONTACT LENSES ALCON INC (CH) 2007-07-25 EP disclosed
EP-1792972-A1 Use of multifuctional surface active agents to clean contact lenses Alcon, Inc. (CH) 2007-06-06 EP disclosed
US-20070010652-A1 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications STEPHANIE ANGOT, OLIVIER BREYNE, AND YOU-PING CHAN 2007-01-11 US disclosed
US-20060251690-A1 Skin enrichment using CoQ10 as the delivery system ZYMES, LLC (US) 2006-11-09 US disclosed
US-20060099264-A1 Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications AVADEL LEGACY PHARMACEUTICALS, LLC 2006-05-11 US disclosed
US-6995123-B2 Use of multifunctional surface active agents to clean contact lenses ALCON, INC. (CH) 2006-02-07 US disclosed
US-20050282715-A1 Use of multifunctional surface active agents to clean contact lenses KETELSON HOWARD A 2005-12-22 US disclosed
EP-1576081-A1 USE OF MULTIFUNCTIONAL SURFACE ACTIVE AGENTS TO CLEAN CONTACT LENSES Alcon, Inc. (CH) 2005-09-21 EP disclosed
WO-2004058929-A1 USE OF MULTIFUNCTIONAL SURFACE ACTIVE AGENTS TO CLEAN CONTACT LENSES ALCON, INC. (CH) 2004-07-15 WO disclosed
US-20040127372-A1 Use of multifunctional surface active agents to clean contact lenses ALCON INC. (CH) 2004-07-01 US disclosed
EP-0968703-B1 Cosmetic or pharmaceutical composition under solid form and being deformable OREAL (FR) 2004-03-24 EP disclosed
US-6630171-B1 Polypeptide polymers of aspartic acid and glutamic acid bearing a hydrophobic group; drug delivery; insulin carrier FLAMEL TECHNOLOGIES (FR) 2003-10-07 US disclosed
EP-1088020-B1 FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF USTAV MAKROMOLEKULARNI CHEMIE (CZ) 2002-12-18 EP disclosed
EP-1135398-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION Monsanto Technology LLC (US) 2001-09-26 EP disclosed
US-6218563-B1 Cyanophosphonamides and method for preparation MONSANTO COMPANY 2001-04-17 US disclosed
EP-1088020-A1 FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF USTAV MAKROMOLEKULARNI CHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) 2001-04-04 EP disclosed
WO-2000032611-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION MONSANTO TECHNOLOGY LLC (US) 2000-06-08 WO disclosed
EP-0968703-A1 Cosmetic or pharmaceutical composition under solid form and being deformable L'OREAL (FR) 2000-01-05 EP disclosed
WO-1999064495-A1 FUNCTIONALISED POLYMERS OF α-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VĚD ČESKÉ REPUBLIKY (CZ) 1999-12-16 WO disclosed
EP-0572167-B1 Cosmetic composition UNILEVER PLC (GB) 1996-10-09 EP disclosed
EP-0572167-A1 Cosmestic composition UNILEVER PLC (GB) 1993-12-01 EP disclosed
EP-0572167-A1 Cosmestic composition UNILEVER PLC (GB) 1993-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060251690-A1 Skin enrichment using CoQ10 as the delivery system NDUFA10, NDUFB10, COQ8A NOD1 3300/4885P2RY10 320/4885GPR34 4796/4885
US-20100098656-A1 Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications SLC7A1, AADAT, SLC7A11 NOD1 4844/4885P2RY10 2690/4885GPR34 893/4885
US-20180280481-A1 PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS SLC30A5, SLC39A11, SLC30A6 NOD1 3431/4885P2RY10 3766/4885GPR34 3294/4885
US-20100034886-A1 Polyglutamic Acids Functionalised by Histidine Derivatives and Hydrophobic Groups and the Uses Thereof, in Particular for Therapeutic Purposes H1-5, H1-0, H1-3 NOD1 2010/4885P2RY10 2164/4885GPR34 1599/4885
US-20100048735-A1 POLYAMINOACIDS FUNCTIONALIZED WTIH ALPHA-TOCOPHEROL, AND USES THEREOF, ESPECIALLY THERAPEUTIC USES GGH, TTPA, ASPH NOD1 4714/4885P2RY10 4005/4885GPR34 1745/4885
US-20240254096-A1 ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS ERCC1, ERCC4, ERCC5 NOD1 2786/4885P2RY10 1908/4885GPR34 2454/4885
US-20070265192-A1 Telechelic Homopolyamino Acids Functionalized with Hydrophobic Groups, and Their Applications, Especially Therapeutic Applications AADAT, DAO, SLC7A1 NOD1 4410/4885P2RY10 1553/4885GPR34 722/4885
US-20160060208-A1 GLUTAMATE DERIVATIVES FOR TOPICAL USE AS IMMUNOMODULATORY ACTIVE INGREDIENT GRM1, GRIN1, GRM2 NOD1 941/4885P2RY10 1521/4885GPR34 431/4885
US-20090305948-A1 Branched Polyamino Acids Functionalized with Hydrophobic Groups, and Applications Thereof Particularly Therapeutic Applications SLC7A1, SLC43A1, BCAT1 NOD1 4853/4885P2RY10 2579/4885GPR34 458/4885
US-20070178126-A1 Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses DNPEP, AADAT, GLUL NOD1 4591/4885P2RY10 1935/4885GPR34 940/4885
US-20060099264-A1 Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications TTPA, ALAD, AADAT NOD1 4828/4885P2RY10 3091/4885GPR34 1501/4885
US-10905744-B2 Pharmaceutical formulations for the oral delivery of peptide drugs SLC30A5, SLC39A11, SLC30A6 NOD1 3431/4885P2RY10 3766/4885GPR34 3294/4885
US-20110044930-A1 COPOLYHYDROXYALKYLGLUTAMINES FUNCTIONALISED WITH HYDROPHOBIC GROUPS, AND USES THEREOF, ESPECIALLY IN THERAPEUTICS SLC7A11, GLUL, GGCT NOD1 4817/4885P2RY10 1868/4885GPR34 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.